Glenn J. Myatt

Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships

Tatiana I. Netzeva, Andrew Worth, Tom Aldenberg et al. · Alternatives to Laboratory Animals · 2005 · 814 citations

Pharmacy, Pharmacology, Drug Design +9

MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes

James Kramer, Carlos A. Obejero‐Paz, Glenn J. Myatt et al. · Scientific Reports · 2013 · 352 citations · Full text

Medicine, Cardiology, Pharmacology +17

In silico toxicology protocols

Glenn J. Myatt, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2018 · 241 citations · Full text

Pharmacy, Toxicology, Developmental Toxicology +11

SPROUT: Recent developments in the de novo design of molecules

Valerie J. Gillet, William H. Newell, Paulina Mata et al. · Journal of Chemical Information and Computer Sciences · 1994 · 180 citations

Pharmacy, Chemistry, Medicinal Chemistry +8

LeadScope:  Software for Exploring Large Sets of Screening Data

Gulsevin Roberts, Glenn J. Myatt, Wayne P. Johnson et al. · Journal of Chemical Information and Computer Sciences · 2000 · 155 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16